David Messenger

2.1k citations

47 papers · 1.1k indexed · h-index 21

Impact in

Oncology top 5%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
Surgery top 5%
- Colorectal and Anal Carcinomas
- Enhanced Recovery After Surgery

Papers in ⓘ

Oncology 30
- Colorectal Cancer Surgical Treatments 24
- Colorectal Cancer Screening and Detection 15
Surgery 29
- Colorectal and Anal Carcinomas 8
- Esophageal and GI Pathology 5
- Enhanced Recovery After Surgery 5

Co-authors: Richard Kirsch (13 shared papers)David K. Driman (7 shared papers)Michael G. Thomas (9 shared papers)Robin S. McLeod (5 shared papers)Robert H. Riddell (7 shared papers)Sally Hallam (3 shared papers)Neil Rasburn (1 shared paper)Nader Francis (6 shared papers)
Journals: Colorectal Disease (6 papers)Diseases of the Colon & Rectum (3 papers)Human Pathology (3 papers)Archives of Pathology & Laboratory Medicine (2 papers)Surgical Endoscopy (2 papers)
Partner nations: United Kingdom Canada United States

In The Last Decade

David Messenger

46 papers receiving 1.1k citations

Peers

Countries citing papers authored by David Messenger

Since Specialization

Citations

This map shows the geographic impact of David Messenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Messenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Messenger more than expected).

Fields of papers citing papers by David Messenger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Messenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Messenger. The network helps show where David Messenger may publish in the future.

Co-authors

The 25 scholars most cited alongside David Messenger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Messenger Line = papers co-authored together David Messenger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer Journal of Thoracic and Cardiovascular Surgery ·Luke Rogers, David Bleetman, David Messenger, Natasha Joshi, Lesley Wood, Neil Rasburn, Tim Batchelor	2017	159
2	Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome Human Pathology ·David Messenger, David K. Driman, Richard Kirsch	2012	86
3	Venous Invasion in Colorectal Cancer The American Journal of Surgical Pathology ·Richard Kirsch, David Messenger, Robert H. Riddell, Aaron Pollett, Megan Cook, Sahar Al‐Haddad, Catherine Streutker, Dimitrios X. G. Divaris, Rajani Pandit, Ken J. Newell, Jimin Liu, Russell G. Price, Sharyn Smith, Jeremy Parfitt, David K. Driman	2012	81
4	Demographic trends in the incidence of young-onset colorectal cancer: a population-based study British journal of surgery ·A Chambers, Steven Dixon, Paul White, Ann C. Williams, Michael G. Thomas, David Messenger	2020	75
5	Factors predicting outcome from enhanced recovery programmes in laparoscopic colorectal surgery: a systematic review Surgical Endoscopy ·David Messenger, Nathan Curtis, Adam Jones, Emma L. Jones, Neil Smart, Nader Francis	2016	65
6	What Impact Has the Introduction of a Synoptic Report for Rectal Cancer Had on Reporting Outcomes for Specialist Gastrointestinal and Nongastrointestinal Pathologists? Archives of Pathology & Laboratory Medicine ·David Messenger, Robin S. McLeod, Richard Kirsch	2011	61
7	A Systematic Review of Local Excision After Neoadjuvant Therapy for Rectal Cancer: Are ypT0 Tumors the Limit? Diseases of the Colon & Rectum ·Sally Hallam, David Messenger, Michael G. Thomas	2016	43
8	Factors predicting 30‐day readmission after laparoscopic colorectal cancer surgery within an enhanced recovery programme Colorectal Disease ·Nader Francis, J. Bradley Mason, Emad Salib, L. Allanby, David Messenger, Andrew Allison, Neil Smart, Jonathan Ockrim	2015	40
9	Current practice patterns among pathologists in the assessment of venous invasion in colorectal cancer Journal of Clinical Pathology ·David Messenger, David K. Driman, Robin S. McLeod, Robert H. Riddell, Richard Kirsch	2011	36
10	A Review of Current Challenges in Colorectal Cancer Reporting Archives of Pathology & Laboratory Medicine ·Heather Dawson, Richard Kirsch, David Messenger, David K. Driman	2019	31
11	Cytokeratin‐based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience The Journal of Pathology Clinical Research ·Viktor H. Koelzer, Naziheh Assarzadegan, Heather Dawson, Bojana Mitrovic, Andrea Grin, David Messenger, Richard Kirsch, Robert H. Riddell, Alessandro Lugli, Inti Zlobec	2017	31
12	The use of artificial neural networks to predict delayed discharge and readmission in enhanced recovery following laparoscopic colorectal cancer surgery Techniques in Coloproctology ·Nader Francis, Alison Luther, Emad Salib, L. Allanby, David Messenger, Andrew Allison, Neil Smart, Jonathan Ockrim	2015	30
13	Do MRI Reports Contain Adequate Preoperative Staging Information for End Users to Make Appropriate Treatment Decisions for Rectal Cancer? Annals of Surgical Oncology ·Eisar Al‐Sukhni, David Messenger, J. Charles Victor, Robin S. McLeod, Erin Kennedy	2012	29
14	Optimizing the Detection of Venous Invasion in Colorectal Cancer: The Ontario, Canada, Experience and Beyond Frontiers in Oncology ·Heather Dawson, Richard Kirsch, David K. Driman, David Messenger, Naziheh Assarzadegan, Robert H. Riddell	2015	26
15	A systematic review of local excision followed by adjuvant therapy in early rectal cancer: are pT1 tumours the limit? Colorectal Disease ·J Cutting, Sally Hallam, Michael G. Thomas, David Messenger	2018	25
16	The incidence and characterization of deep vein thrombosis following ultrasound-guided foam sclerotherapy in 1000 legs with superficial venous reflux Journal of Vascular Surgery Venous and Lymphatic Disorders ·Sachin R. Kulkarni, David Messenger, Fiona Slim, Lorraine G Emerson, Richard Bulbulia, M R Whyman, K R Poskitt	2013	23
17	Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts Molecular Oncology ·George S. Karagiannis, Ann Treacy, David Messenger, Andrea Grin, Richard Kirsch, Robert H. Riddell, Eleftherios P. Diamandis	2014	22
18	Favorable Pathologic and Long-Term Outcomes From the Conventional Approach to Abdominoperineal Resection Diseases of the Colon & Rectum ·David Messenger, Zane Cohen, Richard Kirsch, Brenda I. O’Connor, J. Charles Victor, Harden Huang, Robin S. McLeod	2011	22
19	Symptomatic diaphragmatic herniation following open and minimally invasive oesophagectomy: experience from a UK specialist unit Surgical Endoscopy ·David Messenger, Simon Higgs, Simon Dwerryhouse, D F Hewin, M N Vipond, Hugh Barr, Martin Wadley	2014	21
20	Controversies around gestational diabetes. Practical information for family doctors. PubMed ·Len Kelly, Laura Evans, David Messenger	2005	21

About David Messenger

David Messenger is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (24 papers), Colorectal Cancer Screening and Detection (15 papers), Gastric Cancer Management and Outcomes (9 papers), Genetic factors in colorectal cancer (8 papers), Colorectal and Anal Carcinomas (8 papers), Cardiac, Anesthesia and Surgical Outcomes (6 papers), Esophageal and GI Pathology (5 papers) and Enhanced Recovery After Surgery (5 papers). The work is most often cited by research in Oncology (652 citations), Surgery (652 citations), Cardiology and Cardiovascular Medicine (215 citations), Pulmonary and Respiratory Medicine (268 citations) and Health Informatics (8 citations). David Messenger has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Richard Kirsch, David K. Driman, Michael G. Thomas, Robin S. McLeod, Robert H. Riddell, Sally Hallam, Neil Rasburn, Nader Francis, Lesley Wood and Luke Rogers. Their work appears in journals such as Colorectal Disease, Diseases of the Colon & Rectum, Human Pathology, Archives of Pathology & Laboratory Medicine and Surgical Endoscopy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact